154 related articles for article (PubMed ID: 22994709)
1. Linear and conformational B cell epitope prediction of the HER 2 ECD-subdomain III by in silico methods.
Mahdavi M; Mohabatkar H; Keyhanfar M; Dehkordi AJ; Rabbani M
Asian Pac J Cancer Prev; 2012; 13(7):3053-9. PubMed ID: 22994709
[TBL] [Abstract][Full Text] [Related]
2. In silico design of discontinuous peptides representative of B and T-cell epitopes from HER2-ECD as potential novel cancer peptide vaccines.
Manijeh M; Mehrnaz K; Violaine M; Hassan M; Abbas J; Mohammad R
Asian Pac J Cancer Prev; 2013; 14(10):5973-81. PubMed ID: 24289611
[TBL] [Abstract][Full Text] [Related]
3. Immunization with a novel chimeric peptide representing B and T cell epitopes from HER2 extracellular domain (HER2 ECD) for breast cancer.
Mahdavi M; Keyhanfar M; Jafarian A; Mohabatkar H; Rabbani M
Tumour Biol; 2014 Dec; 35(12):12049-57. PubMed ID: 25142233
[TBL] [Abstract][Full Text] [Related]
4. In silico prediction of B cell epitopes of the extracellular domain of insulin-like growth factor-1 receptor.
Bayrami V; Keyhanfar M; Mohabatkar H; Mahdavi M; Moreau V
Mol Biol Res Commun; 2016 Dec; 5(4):201-214. PubMed ID: 28261624
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of evolutionarily conserved motifs of epidermal growth factor receptor 2 (HER2) predicts novel potential therapeutic epitopes.
Deng X; Zheng X; Yang H; Moreira JM; Brünner N; Christensen H
PLoS One; 2014; 9(9):e106448. PubMed ID: 25192037
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of new HER2 peptide vaccination based on B cell epitope.
Miyako H; Kametani Y; Katano I; Ito R; Tsuda B; Furukawa A; Saito Y; Ishikawa D; Ogino K; Sasaki S; Imai K; Habu S; Makuuchi H; Tokuda Y
Anticancer Res; 2011 Oct; 31(10):3361-8. PubMed ID: 21965747
[TBL] [Abstract][Full Text] [Related]
7. Epitope Mapping of Human HER2 Specific Mouse Monoclonal Antibodies Using Recombinant Extracellular Subdomains.
Hosseini Ghatar R; Soltantoyeh T; Bahadori T; Golara M; Hassannia H; Khosravi Eghbal R; Khoshnoodi J; Judaki MA; Golsaz-Shirazi F; Jeddi-Tehrani M; Amiri MM; Shokri F
Asian Pac J Cancer Prev; 2017 Nov; 18(11):3103-3110. PubMed ID: 29172286
[TBL] [Abstract][Full Text] [Related]
8. B-cell epitopes of antigenic proteins in Leishmania infantum: an in silico analysis.
Assis LM; Sousa JR; Pinto NF; Silva AA; Vaz AF; Andrade PP; Carvalho EM; De Melo MA
Parasite Immunol; 2014 Jul; 36(7):313-23. PubMed ID: 24606067
[TBL] [Abstract][Full Text] [Related]
9. Production and Characterization of New Anti-HER2 Monoclonal Antibodies.
Mahdavi M; Keyhanfar M; Jafarian A; Mohabatkar H; Rabbani M
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):213-21. PubMed ID: 26090600
[TBL] [Abstract][Full Text] [Related]
10. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
11. A linear region of a monoclonal antibody conformational epitope mapped on p185HER2 oncoprotein.
Orlandi R; Formantici C; Ménard S; Boyer CM; Wiener JR; Colnaghi M
Biol Chem; 1997 Nov; 378(11):1387-92. PubMed ID: 9426199
[TBL] [Abstract][Full Text] [Related]
12. Prediction of linear B-cell epitopes.
Reimer U
Methods Mol Biol; 2009; 524():335-44. PubMed ID: 19377956
[TBL] [Abstract][Full Text] [Related]
13. Polyclonal Antibody against Different Extracellular Subdomains of HER2 Induces Tumor Growth Inhibition in vitro.
Hosseini Ghatar R; Soltantoyeh T; Bahadori M; Khoshnoodi J; Golsaz Shirazi F; Jeddi Tehrani M; Amiri MM; Shokri F
Iran J Immunol; 2017 Sep; 14(3):200-214. PubMed ID: 28919583
[TBL] [Abstract][Full Text] [Related]
14. Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu.
Garrett JT; Rawale S; Allen SD; Phillips G; Forni G; Morris JC; Kaumaya PT
J Immunol; 2007 Jun; 178(11):7120-31. PubMed ID: 17513761
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics and immunologic investigation on B and T cell epitopes of Cur l 3, a major allergen of Curvularia lunata.
Sharma V; Singh BP; Gaur SN; Pasha S; Arora N
J Proteome Res; 2009 Jun; 8(6):2650-5. PubMed ID: 19290623
[TBL] [Abstract][Full Text] [Related]
16. Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities.
Dakappagari NK; Lute KD; Rawale S; Steele JT; Allen SD; Phillips G; Reilly RT; Kaumaya PT
J Biol Chem; 2005 Jan; 280(1):54-63. PubMed ID: 15507452
[TBL] [Abstract][Full Text] [Related]
17. Beyond B-Cell Epitopes: Curating Positive Data on Antipeptide Paratope Binding to Support Peptide-Based Vaccine Design.
Caoili SEC
Protein Pept Lett; 2021; 28(8):953-962. PubMed ID: 33602065
[TBL] [Abstract][Full Text] [Related]
18. Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).
Gabrielli F; Salvi R; Garulli C; Kalogris C; Arima S; Tardella L; Monaci P; Pupa SM; Tagliabue E; Montani M; Quaglino E; Stramucci L; Curcio C; Marchini C; Amici A
PLoS One; 2013; 8(3):e58358. PubMed ID: 23555577
[TBL] [Abstract][Full Text] [Related]
19. Predicted B-cell epitopes of HER-2 oncoprotein by a bioinformatics method: a clue for breast cancer vaccine development.
Wiwanitkit V
Asian Pac J Cancer Prev; 2007; 8(1):137-8. PubMed ID: 17477789
[TBL] [Abstract][Full Text] [Related]
20. Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies.
Rockberg J; Schwenk JM; Uhlén M
Mol Oncol; 2009 Jun; 3(3):238-47. PubMed ID: 19393584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
